Can You Buy GLP-1 in Canada? Your Comprehensive Guide

Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonists have transformed weight management, with clinical trials showing average weight loss of 15% over 68 weeks. Canadian patients seeking semaglutide or tirzepatide often encounter lengthy waitlists, provincial coverage restrictions, and prices exceeding $300 monthly. PlexusDx offers an alternative pathway: compounded GLP-1 medications manufactured in licensed 503A US pharmacies, available to Canadian residents without insurance requirements or membership fees.

GLP-1 Availability in Canada: Current Supply and Cost Barriers

Brand-name semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro) remain tightly rationed across Canada's provincial health systems. Many provinces restrict coverage to patients with type 2 diabetes or BMI ≥40, leaving most weight-loss candidates ineligible for public funding. Private pharmacy prices in Canada typically range from $300 to $500 monthly, and compounding options within Canada remain limited compared to US alternatives.

Supply shortages persist due to manufacturing constraints and international demand surges. Some Canadian pharmacies report 3–6 month waitlists for brand-name products. This gap has created significant interest in cross-border sourcing and licensed US compounding as viable pathways for Canadian patients seeking timely, affordable access to GLP-1 therapy.

How Canadians Can Access Compounded GLP-1 from Licensed US Pharmacies

PlexusDx operates in all 50 US states and serves Canadian patients through licensed 503A compounding pharmacies—the gold standard for pharmaceutical compounding. Canadian residents can work with PlexusDx via telemedicine consultation, receive a prescription, and have compounded semaglutide or tirzepatide shipped across the border. This pathway is legal, provided the patient holds a valid prescription from a licensed practitioner and the medication is for personal use (not commercial resale).

Compounded medications from 503A pharmacies undergo rigorous quality testing and are manufactured to pharmaceutical-grade standards. PlexusDx's compounded semaglutide injection starts at $149 monthly, significantly lower than Canadian brand-name prices. No insurance is required, no membership fees apply, and shipping to Canada is available, making it a transparent, accessible option for cross-border patients.

Cost Comparison: Canadian vs. PlexusDx Compounded Options

Brand-name Ozempic or Wegovy in Canada costs $350–$500 per month without provincial coverage. Private Canadian compounding typically ranges from $250–$350 monthly. PlexusDx compounded semaglutide injection starts at $149 per month, representing a 60–70% cost reduction for comparable therapy. Oral semaglutide is available at $249 monthly, and dual-compound GLP-Squared (semaglutide plus tirzepatide) starts at $249 for the injection formulation.

Beyond cost, PlexusDx removes several barriers Canadian patients face: no waitlists, no provincial eligibility restrictions, and HSA/FSA eligibility for US-based patients. The pricing structure remains flat across dose levels—your dose may need to go up, but your price won't—ensuring predictable, long-term affordability without surprise escalations.

Precision Genetic Testing: Personalize Your GLP-1 Therapy

Not every GLP-1 candidate responds identically. PlexusDx Precision Peptide Genetic Test ($99 add-on after first month) maps 14 metabolic and appetite-control pathways, analyzing 49 peptides and 150+ genetic insights. Key variants—GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313—directly influence GLP-1 efficacy and side-effect tolerance. This testing identifies whether semaglutide, tirzepatide, or a dual-compound approach aligns best with your genetic architecture.

Canadian patients often pay $129-$369/mo out-of-pocket for similar testing through private labs. PlexusDx integrates genetic insights into personalized therapy plans, allowing practitioners to titrate dose, choose formulation (injection vs. oral), and monitor outcomes with precision. This genetic-first approach reduces trial-and-error cycles and optimizes long-term success.

Legal and Safety Considerations for Cross-Border GLP-1 Access

Cross-border medication shipment is lawful when prescribed by a licensed practitioner and intended for personal use. Canadian customs permits single-patient quantities of prescription medications as long as they pose no public health risk. PlexusDx works exclusively with licensed 503A compounding pharmacies—never 503B bulk facilities—ensuring pharmaceutical integrity and traceability. Each shipment includes documentation of drug origin, potency testing results, and sterility certification.

Consulting with a Canadian physician before starting compounded GLP-1 is recommended, though not strictly required for cross-border acquisition. PlexusDx practitioners verify patient eligibility, screen for contraindications (active pancreatitis, personal history of medullary thyroid cancer, pregnancy), and provide ongoing clinical oversight. Side effects are monitored via regular check-ins; common experiences include nausea, vomiting, and appetite suppression, which typically subside within 2–4 weeks.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is it legal for Canadians to order compounded GLP-1 from the US?

Yes. Canadian residents can legally import prescription medications for personal use, including compounded semaglutide and tirzepatide from licensed US 503A pharmacies. The medication must be prescribed by a licensed practitioner and intended for personal consumption, not resale. PlexusDx operates within these legal parameters across all provinces.

How long does it take to receive GLP-1 medication from PlexusDx to Canada?

Standard shipping to Canada typically takes 7–10 business days after prescription verification and pharmacy processing. Expedited shipping is available upon request. PlexusDx provides tracking information and confirms shipment status via email, ensuring transparency throughout the delivery process.

What is the difference between PlexusDx compounded and brand-name GLP-1?

PlexusDx compounded medications contain the same active pharmaceutical ingredient (semaglutide or tirzepatide) as brand-name products, manufactured under 503A pharmacy standards with equivalent potency testing. The primary differences are cost (compounded starts at $149 vs.

Can I switch between semaglutide and tirzepatide if one isn't working?

Yes. If semaglutide isn't delivering expected results after 8–12 weeks, PlexusDx practitioners can transition you to tirzepatide (a dual GIP/GLP-1 agonist) or GLP-Squared, the dual-compound formulation combining both agents.

What does the PlexusDx Precision Peptide Genetic Test reveal?

The test analyzes 14 metabolic pathways and 49 peptides, including key variants in GLP1R, GIPR, FTO, and MC4R genes. Results show whether your genetic profile favors semaglutide (GLP-1 dominant), tirzepatide (dual GIP/GLP-1 response), or a personalized compound formulation.

Are PlexusDx medications covered by Canadian health insurance?

PlexusDx compounded medications are not covered by provincial health plans, but they are HSA/FSA eligible for US-based patients. Canadian patients pay out-of-pocket; however, the $149/month starting price for compounded semaglutide is substantially lower than private Canadian alternatives ($300–$500), offsetting the lack of insurance coverage.

Related Reading

• How To Buy Glp 1
• Where To Buy Glp 1
• Buy Glp 1 Online
• Can You Get Your Glp 1 Tested

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.